Company performance
Add to research
Current Price
as of May 23, 2025$9.02
P/E Ratio
N/A
Market Cap
$955.08M
Description
Add to research
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology, and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.
Metrics
Add to research
Overview
- HQHayward, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerRCUS
- Price$9.02+2.73%
Trading Information
- Market cap$955.08M
- Float60.34%
- Average Daily Volume (1m)1,168,827
- Average Daily Volume (3m)1,163,470
- EPS-$4.19
Company
- Revenue$141.00M
- Rev growth (1yr)-80.69%
- Net income-$112.00M
- Gross margin89.29%
- EBITDA margin-425.00%
- EBITDA-$119.00M
- EV-$164.56M
- EV/Revenue-1.17
- P/EN/A
- P/S6.29
- P/B1.80
- Debt/Equity11.30
Documents
Add to research
SEC Filings
Factset Street Account